Beyond the margins: Economic costs and complication rates associated with repeated breast-conserving surgeries.

Authors

null

Leanne N. Metcalfe

Health Care Services Corporation, Richardson, TX

Leanne N. Metcalfe , Adam M. Zysk , Gerald Edelman , Lan Vu , Andrew J. Cittadine , Kathryn B. Hyer , Alastair Mark Thompson

Organizations

Health Care Services Corporation, Richardson, TX, Diagnostic Photonics, Inc., Chicago, IL, Medical Surgical Clinic of Irving, Irving, TX, The University of Texas MD Anderson Cancer Center, Houston, TX

Research Funding

Other

Background: Considerable attention has been paid to the problem of repeated breast-conserving surgery (BCS; i.e., lumpectomy), but the costs and complications due to these additional operations are not well-characterized. To address this issue, a retrospective review of insurance claims data for BCS patients was performed to assess complications and economic outcomes. Methods: Private claims from a single insurer were analyzed for 9,457 women undergoing BCS for breast carcinoma between January 2010 and September 2013 in either Illinois, New Mexico, Oklahoma, or Texas. Patients undergoing a second open breast surgery (i.e., mastectomy or BCS) within 90 days of the initial BCS were classified as having a repeated surgery. Complications were identified via a set of 8 CPT and 25 ICD9 diagnosis and procedure codes related to breast cancer treatment. The analysis included these complications and the total cost of all allowed healthcare claims within two years following diagnosis. Results: 7,287/9,457 patients (77% ±0.9%, 95% confidence interval) had one BCS operation and 2,170 patients (23% ±0.9%) had at least one repeated surgery (Table). The mean patient age was 53 years. The mean two-year cost for patients undergoing a single BCS was $88,733 (±$1,884) and the cost for patients undergoing a repeated breast surgery was $104,482 (±$3,719), $99,554 for a second BCS and $117,967 for subsequent mastectomy. The mean added cost due to a repeated surgery was $16,352. The percentage of patients experiencing at least one complication was 23.7% (±1.0) for those undergoing one BCS only and 35.2% (±2.0) for those undergoing a repeated surgery. Conclusions: For the 23% of women undergoing a second operation after BCS, complications were 49% more common and the mean total cost of surgery increased more than $16,000, demonstrating a patient-centered and fiscal imperative to reduce reoperations in BCS for breast cancer.

BCS,
No Repeat
Repeated Breast Surgery
Repeated BCSConvert to Mastectomy
Patients7,2871511659
Percentage77%16%7%
Patients with Complication(s)1,729497267
Percentage24%33%41%
Mean Two-Year Cost Per Patient$88,733$99,554$117,967

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Abstract Details

Meeting

2016 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Breast Cancer—Triple-Negative/Cytotoxics/Local Therapy

Track

Breast Cancer

Sub Track

Local Therapy

Citation

J Clin Oncol 34, 2016 (suppl; abstr 1050)

DOI

10.1200/JCO.2016.34.15_suppl.1050

Abstract #

1050

Poster Bd #

155

Abstract Disclosures